OTC · Financial Statements
AXIM Biotechnologies, Inc. (AXIM) Financial Statements
$0.00
OTC: AXIM
Market Cap $1.02M
Overview Financials Dividend AXIM Biotechnologies, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-8.0M $-5.0M $-3.0M $-2.0M $-1.0M Net Profit $-17.0M $-6.0M $-8.0M $-4.0M $-1.0M EPS $-0.13 $-0.04 $-0.04 $-0.01 $0.00 Op Margin -13207.1% -52425.6% -6961.0% -2502.3% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $5.0M $4.0M $4.0M $3.0M $3.0M Total Liabilities $8.0M $9.0M $12.0M $14.0M $14.0M Cash $0 $0 $0 $0 $0 Borrowings $7.0M $6.0M $6.0M $7.0M $8.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-2.0M $-1.0M $-1.0M $-1.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $2.0M $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $0 $0 Free Cash Flow $-3.0M $-2.0M $-1.0M $-1.0M $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -28.98 FCF Yield 4.11% Quick Ratio 0.00 Interest Coverage -3.43 Return 1Y -50.00% Return 3Y -89.66% Return 5Y -99.57%
Screens featuring this stock